Abstract
The effects of Oral Anticoagulation Therapy (OAT) in older patients who suffered a mild Traumatic Brain Injury (mTBI) are widely debated but still strong guidelines are lacking and clinical approaches and management are sometimes heterogeneous. Different predictors of adverse outcomes were identified in the literature but their use in the decision-making process is unclear. Moreover, there is no consensus on the appropriate length of stay in the Observation Unit nor on the continuation of OAT, even if the diagnosis of life-threatening delayed post-traumatic Intracranial Hemorrhage is rare. The recurrence of a control CT scan is often needless. This review aims to summarize recent scientific literature focusing on patients with mTBI taking OAT and to identify crucial questions on the topic to suggest a best clinical practice.
Reference68 articles.
1. Gelbard R, Inaba K, Okoye OT, et al. Falls in the elderly: A modern look at an old problem. Am J Surg 2014;208:249-53.
2. TAaRN. Major trauma in older people. Salford, UK: University of Manchester, Manchester Academic Health Science Centre, 2018. Available from: https://www.tarn.ac.uk/content/downloads/3793/Major%20Trauma%20in%20Older%20People%202017.pdf
3. Prisco D, Ageno W, Becattini C, et al. Italian intersociety consensus on DOAC use in internal medicine. Intern Emerg Med 2017;12:387-406.
4. Pieracci FM, Eachempati SR, Shou J, et al. Use of long-term anticoagulation is associated with traumatic intracranial hemorrhage and subsequent mortality in elderly patients hospitalized after falls: Analysis of the New York State Administrative Database. J Trauma 2007;63:519-24.
5. Spaniolas K, Cheng JD, Gestring ML, et al. Ground level falls are associated with significant mortality in elderly patients. J Trauma 2010;69:821-5.